767
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Effect of a fermented dietary supplement containing chromium and zinc on metabolic control in patients with type 2 diabetes: a randomized, placebo-controlled, double-blind cross-over study

, , &
Article: 30298 | Received 05 Nov 2015, Accepted 23 May 2016, Published online: 23 Jun 2016

References

  • Hauner H, Bramlage P, Lösch C, Steinhagen-Thiessen E, Schunkert H, Wasem J, etal. Prevalence of obesity in primary care using different anthropometric measures – results of the German Metabolic and Cardiovascular Risk Project (GEMCAS). BMC Public Health. 2008; 8(1): 282.
  • Köster I, Huppertz E, Hauner H, Schubert I. Direct costs of diabetes mellitus in Germany CoDiM 2000–2007. Exp Clin Endocrinol Diabetes. 2011; 119(6): 377–85.
  • Koh-Banerjee P, Wang Y, Hu FB, Spiegelman D, Willett WC, Rimm EB. Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men. Am J Epidemiol. 2004; 159: 1150–9.
  • Bartlett HE, Eperjesi F. Nutritional supplementation for type 2 diabetes: a systematic review. Ophthalmic Physiol Opt. 2008; 28: 503–23.
  • Wiernsperger N, Rapin JR. Trace elements in glucometabolic disorders. Diabetol Metab Syndr. 2010; 2: 70–8.
  • Davi G, Santilli F, Patrono C. Nutraceuticals in diabetes and metabolic syndrome. Cardiovasc Ther. 2010; 28: 216–26.
  • Cefalu WT, Hu FB. Role of chromium in human health and in diabetes. Diabetes Care. 2004; 27: 2741–51.
  • Cefalu WT, Wang ZQ, Zhang XH, Baldor LC, Russell JC. Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats. J Nutr. 2002; 132(6): 1107–14. [PubMed Abstract].
  • Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR, Bruce-Robertson A. Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr. 1977; 30: 531–8. [PubMed Abstract].
  • Martin J, Wang ZQ, Zhang XH, Wachtel D, Volaufova J, Matthews DE, etal. Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes. Diabetes Care. 2001; 29: 1826–32.
  • Racek J, Trefil L, Rajdl D, Mudrova V, Hunter D, Senfrl V. Influence of chromium-enriched yeast on blood glucose and insulin variables, blood lipids, and markers of oxidative stress in subjects with type 2 diabetes mellitus. Biol Trace Elem Res. 2006; 109: 215–30.
  • Rabinovitz H, Friedensohn A, Leibovitz A, Gabay G, Rocas C, Habot B. Effect of chromium supplementation on blood glucose and lipid levels in type 2 diabetes mellitus elderly patients. Int J Vitam Nutr Res. 2004; 74: 178–82.
  • Ghosh D, Bhattacharya B, Mukherjee B, Manna B. Role of chromium supplementation in Indians with type 2 diabetes mellitus. J Nutr Biochem. 2002; 13: 690–7.
  • Bahijiri SM, Mira SA, Mufti AM, Ajabnoor MA. The effects of inorganic chromium and brewers yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with type 2 diabetes. Saudi Med J. 2000; 21: 831–7. [PubMed Abstract].
  • Anderson RA, Cheng NZ, Bryden NA, Polansky MM, Cheng NP, Chi JM, etal. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes. 1997; 46: 1786–91.
  • Balk EM, Tatsioni A, Lichtenstein AH, Lau J, Pittas AG. Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials. Diabetes Care. 2007; 30: 2154–63.
  • Haase H, Overbeck S, Rink L. Zinc supplementation for the treatment or prevention of disease: current status and future perspectives. Exp Gerontol. 2008; 43(5): 394–408.
  • Arnaud J, Faure H, Bourlard P, Denis B, Favier AE. Longitudinal changes in serum zinc concentration and distribution after acute myocardial infarction. Clin Chim Acta. 1994; 230(2): 147–56.
  • Wijesekara N, Chimienti F, Wheeler MB. Zinc, a regulator of islet function and glucose homeostasis. Diabetes Obes Meta. 2009; 11: 202–14.
  • Ilouz R, Kaidanovich O, Gurwitz D, Eldar-Finkelman H. Inhibition of glycogen synthase kinase-3ß by bivalent zinc ions: insight into the insulin-mimetic action of zinc. Biochem Biophys Res Commun. 2002; 295(1): 102–6.
  • Saper RB, Rash R. Zinc: an essential micronutrient. Am Fam Physician. 2009; 79(9): 768–72. [PubMed Abstract] [PubMed CentralFull Text].
  • Prasad A. Clinical, immunological, anti-inflammatory and antioxidant roles of zinc. Exp Gerontol. 2008; 43(5): 370–7.
  • Afridi HI, Kazi TG, Kazi N, Baig JA, Jamali MK, Arain MB, etal. Status of essential trace metals in biological samples of diabetic mother and their neonates. Arch Gynecol Obstet. 2009; 280(3): 415–23.
  • Kazi TG, Afridi HI, Kazi N, Jamali MK, Arain MB, Jalbani N, etal. Copper, chromium, manganese, iron, nickel, and zinc levels in biological samples of diabetes mellitus patients. Biol Trace Elem Res. 2008; 122(1): 1–18.
  • Al-Maroof RA, Al-Sharbatti SS. Serum zinc levels in diabetic patients and effect of zinc supplementation on glycemic control of type 2 diabetics. Saudi Med J. 2006; 27(3): 344–50. [PubMed Abstract].
  • Gunasekara P, Hettiarachchi M, Liyanage C, Lekamwasam S. Effects of zinc and multimineral vitamin supplementation on glycemic and lipid control in adult diabetes. Diabetes Metab Syndr Obes. 2011; 4: 53–60. [PubMed Abstract] [PubMed CentralFull Text].
  • Jayawardena R, Ranasinghe P, Galappathy P, Malkanthi RLDK, Constantine GR, Katulanda P. Effects of zinc supplementation on diabetes mellitus: a systematic review and meta-analysis. Diabetol Metab Syndr. 2012; 4: 13–24.
  • Latis S, Grammatikou S, Poulia KA, Perrea D, Makrilakis K, Diakoumopoulou E, etal. Vinegar reduces postprandial hyperglycaemia in patients with type II diabetes when added to a high, but not a low glycaemic index meal. Eur J Clin Nutr. 2010; 64: 727–32.
  • Ogawa N, Satsu H, Watanabe H, Fukaya M, Tsukamoto Y, Miyamoto Y, etal. Acetic acid suppresses the increase in disaccharidase activity that occurs during culture of caco-2 cells. J Nutr. 2000; 130: 507–13. [PubMed Abstract].
  • Liljeberg H, Bjorck I. Delayed gastric emptying rate may explain improved glycaemia in healthy subjects to a starchy meal with added vinegar. Eur J Clin Nutr. 1998; 52: 368–71.
  • Östmann E, Granfeldt Y, Persson L, Björck I. Vinegar supplementation lowers glucose and insulin responses and increases satiety after a bread meal in healthy subjects. Eur J Clin Nutr. 2005; 59: 983–8.
  • Johnston CS, Steplewska I, Long CA, Harris LN. Examination of the antiglycemic properties of vinegar in healthy adults. Ann Nutr Metab. 2010; 56: 74–9.
  • Hills M, Armitage P. The two-period cross-over clinical trial. Br J Clin Pharmacol. 1979; 8(1): 7–20.
  • Clodfelder BJ, Gullick BM, Lukaski HC, Neggers Y, Vincent JB. Oral administration of the biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ increases insulin sensitivity and improves blood plasma variables in healthy and type 2 diabetic rats. J Biol Inorg Chem. 2005; 10(2): 119–30.
  • Deutsche Gesellschaft für Ernährung (DGE). D-A-CH: Referenzwerte für die Nährstoffzufuhr. 2013; Neustadt: Umschau Buchverlag. 5th ed.
  • Morris BW, MacNeil S, Hardisty CA, Heller S, Burgin C, Gray TA. Chromium homeostasis in patients with type II (NIDDM) diabetes. J Trace Elem Med Biol. 1999; 13(1–2): 57–61.
  • Anderson RA, Roussel A, Zouari N, Mahjoub S, Matheau J, Kerkeni A. Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus. J Am Coll Nutr. 2001; 20: 212–18.
  • Roussel A, Kerkeni A, Zouari N, Mahjoub S, Matheau J, Anderson RA. Antioxidant effects of zinc supplementation in Tunisians with type 2 diabetes mellitus. J Am Coll Nutr. 2003; 22: 316–21.